Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ALKS
CAI
Add up to 3 more stocks
ALKS
Alkermes plc
-2.03%
$41.89-0.87Delayed quote: Oct 6, 2026, 2:25 PM EDT
Market Cap
$7.03B
52W Range
$27.00 - $55.67
CAI
Caris Life Sciences, Inc.
-8.59%
$27.78-2.61Delayed quote: Oct 6, 2026, 2:25 PM EDT
Market Cap
$7.85B
52W Range
$14.19 - $33.66
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 109.38 | 77.62 |
| Forward P/E | N/A | 239.42 |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 3.89 | 13.27 |
| P/S Ratio | 4.21 | 7.94 |
| P/FCF Ratio | 31.71 | 53.61 |
| EV/EBITDA | 45.21 | 43.75 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 84.6% | 69.7% |
| Operating Margin | 17.2% | 5.6% |
| Net Margin | 4.0% | 10.6% |
| ROE | 3.7% | 17.8% |
| ROA | 1.5% | 8.6% |
| ROIC | 2.1% | 14.8% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 2.30 | 5.53 |
| Quick Ratio | 1.85 | 4.88 |
| Debt/Equity | 0.87 | 0.76 |
| Interest Coverage | 20.69 | 0.79 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.